A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings. The new ...

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...

A contact form is often the first real interaction between your brand and a potential customer. Done well, it builds trust ...

A custom label printer in Wilmington is permanently closing, adding to a growing list of Massachusetts manufacturers that have shut down or moved operations elsewhere as the state’s manufacturing ...

Send this article to your social connections.

As the chilly air settles in and those cozy nights by the fire start calling your name, many of us find ourselves reaching for space heaters. They're compact, portable, and can quickly turn your cold ...

An inherent principle of publication is that others should be able to replicate and build upon the authors' published claims. A condition of publication in a Nature Portfolio journal is that authors ...